Obesity drug rivals aim to unseat Zepbound, Ozempic - Indianapolis Business Journal

Published on 3 May 2024 on Indianapolis Business Journal

Insatiable demand for weight-loss drugs has made the market so feverish that any positive mention of...

Read the rest of the article

Start tracking your investments with Statfolio

Tesla CEO Elon Musk does not seem to agree with Republicans at least on one thing. On Wednesday, ...

Benzinga 9 May 2024

GSK expands collaboration with BioVersys AG and invests in their latest funding round, propelling...

Seeking Alpha 7 May 2024

For Immediate Release Chicago, IL – May 6, 2024 – Zacks.com announces the list of stocks featured...

Zacks via Yahoo Finance 6 May 2024

Insight into the Fund's Latest Investment Decisions and Stock Adjustments Vanguard Health Care Fu...

GuruFocus.com via Yahoo Finance 3 May 2024

Thursday, May 3, 2024The Zacks Research Daily presents the best research output of our analyst te...

Zacks via Yahoo Finance 3 May 2024

(NASDAQ: ONCY) (TSX: ONC), Celcuity Inc. (NASDAQ: CELC), Olema Pharmaceuticals, Inc. (NASDAQ: OLM...

WTNH-TV New Haven 3 May 2024

Insatiable demand for weight-loss drugs has made the market so feverish that any positive mention...

Indianapolis Business Journal 3 May 2024

(NASDAQ: ONCY) (TSX: ONC), Celcuity Inc. (NASDAQ: CELC), Olema Pharmaceuticals, Inc. (NASDAQ: OLM...

FOX 4 Kansas City 3 May 2024

(Bloomberg) -- Novo Nordisk A/S shares fell as a US rival’s comments on an experimental obesity d...

Bloomberg via Yahoo Finance 3 May 2024

AstraZeneca PLC (NASDAQ:AZN) Q1 2024 Earnings Call Transcript April 25, 2024 AstraZeneca PLC miss...

Insider Monkey via Yahoo Finance 30 Apr 2024